Advertisement
  • Loading metrics

PLoS Medicine Issue Image | Vol. 15(2) February 2018

PLoS Medicine Issue Image | Vol. 15(2) February 2018

PLOS
x
  • Article
  • Metrics
  • Comments
  • Media Coverage

Setbacks in Alzheimer's research demand new strategies, not surrender

Despite heavy research investments, there has been little if any progress towards an effective treatment for Alzheimer's disease, and leading pharmaceutical company Pfizer recently shuttered its research programs into the disease. On the one-year anniversary of the Special Issue on Dementia, the PLOS Medicine Editors discuss the challenges of addressing a growing population with Alzheimer disease and dementia amidst disappointing news from the pharmaceutical industry. Repeated failures demand new strategies, and an aging population requires action, not surrender.

Image Credit: Daw8ID, Pixabay

thumbnail
Setbacks in Alzheimer's research demand new strategies, not surrender

Despite heavy research investments, there has been little if any progress towards an effective treatment for Alzheimer's disease, and leading pharmaceutical company Pfizer recently shuttered its research programs into the disease. On the one-year anniversary of the Special Issue on Dementia, the PLOS Medicine Editors discuss the challenges of addressing a growing population with Alzheimer disease and dementia amidst disappointing news from the pharmaceutical industry. Repeated failures demand new strategies, and an aging population requires action, not surrender.

Image Credit: Daw8ID, Pixabay

https://doi.org/10.1371/image.pmed.v15.i02.g001